FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894889508> ?p ?o ?g. }

• W2894889508 endingPage "1325" @default.
• W2894889508 startingPage "1314" @default.
• W2894889508 abstract "As loss from HIV care is an ongoing challenge globally, interventions are needed for patients who don't achieve or maintain ART stability. The 2015 South African National Adherence Guidelines (AGL) for Chronic Diseases include two interventions targeted at unstable patients: early tracing of patients who miss visits (TRIC) and enhanced adherence counselling (EAC).As part of a cluster-randomised evaluation at 12 intervention and 12 control clinics in four provinces, intervention sites implemented the AGL interventions, while control sites retained standard care. We report on outcomes of EAC for patients with an elevated viral load (>400 copies/ml) and for TRIC patients who missed a visit by >5 days. We estimated risk differences (RD) of 3 and 12-month viral resuppression (<400 copies/ml) and 12-month retention with cluster adjustment using generalised estimating equations and controlled for imbalances using difference-in-differences compared to all eligible in 2015, prior to intervention roll-out.For EAC, we had 358 intervention and 505 control site patients (61% female, median ART initiation CD4 count 154 cells/μl). We found no difference between arms in 3-month resuppression (RD: -1.7%; 95%CI: -4.3% to 0.9%), but <20% of patients had a repeat viral load within 3 months (19.8% intervention, 13.5% control). Including the entire clinic population eligible for EAC with a repeat viral load at all evaluation sites (n = 934), intervention sites showed a small increase in 3-month resuppression (28% vs. 25%, RD 3.0%; 95%CI: -2.7% to 8.8%). Adjusting for baseline differences increased the RD to 8.1% (95% CI: -0.1% to 17.2%). However, we found no differences in 12-month suppression (RD: 1.5%; 95% CI: -14.1% to 17.1% but suppression was low overall at 40%) or retention (RD: 2.8%; 95% CI: -7.5% to 13.2%). For TRIC, we enrolled 155 at intervention sites and 248 at control sites (44% >40 years, 67% female, median CD4 count 212 cells/μl). We found no difference between groups in return to care by 12 months (RD: -6.8%; 95% CI: -17.7% to 4.8%). During the study period, control sites continued to use tracing within standard care, however, potentially masking intervention effects.Enhanced adherence counselling showed no benefit over 12 months. Implementation of the tracing intervention under the new guidelines was similar to the standard of care. Interventions that aim to return unstable patients to care should incorporate active monitoring to determine if the interventions are effective." @default.
• W2894889508 created "2018-10-12" @default.
• W2894889508 creator A5003785343 @default.
• W2894889508 creator A5006791605 @default.
• W2894889508 creator A5015175349 @default.
• W2894889508 creator A5017211412 @default.
• W2894889508 creator A5024496236 @default.
• W2894889508 creator A5066253506 @default.
• W2894889508 creator A5071119117 @default.
• W2894889508 creator A5074213191 @default.
• W2894889508 creator A5074838021 @default.
• W2894889508 creator A5076063143 @default.
• W2894889508 date "2018-10-24" @default.
• W2894889508 modified "2023-10-14" @default.
• W2894889508 title "Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster-randomised evaluation" @default.
• W2894889508 cites W1528013745 @default.
• W2894889508 cites W1531725059 @default.
• W2894889508 cites W1972391449 @default.
• W2894889508 cites W1977510678 @default.
• W2894889508 cites W1997701594 @default.
• W2894889508 cites W2012646589 @default.
• W2894889508 cites W2055868383 @default.
• W2894889508 cites W2079766092 @default.
• W2894889508 cites W2094200572 @default.
• W2894889508 cites W2098194076 @default.
• W2894889508 cites W2108555579 @default.
• W2894889508 cites W2108966822 @default.
• W2894889508 cites W2112273750 @default.
• W2894889508 cites W2115313777 @default.
• W2894889508 cites W2120637537 @default.
• W2894889508 cites W2127832030 @default.
• W2894889508 cites W2141741448 @default.
• W2894889508 cites W2148841767 @default.
• W2894889508 cites W2149194223 @default.
• W2894889508 cites W2152505869 @default.
• W2894889508 cites W2159899509 @default.
• W2894889508 cites W2183625242 @default.
• W2894889508 cites W2363480212 @default.
• W2894889508 cites W2461327773 @default.
• W2894889508 cites W2509432012 @default.
• W2894889508 cites W2558188285 @default.
• W2894889508 cites W2618831189 @default.
• W2894889508 cites W2620172771 @default.
• W2894889508 cites W2622950545 @default.
• W2894889508 cites W2734969121 @default.
• W2894889508 cites W2736103568 @default.
• W2894889508 cites W2746415643 @default.
• W2894889508 cites W2758364227 @default.
• W2894889508 cites W2793839016 @default.
• W2894889508 cites W2808068978 @default.
• W2894889508 doi "https://doi.org/10.1111/tmi.13152" @default.
• W2894889508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30281882" @default.
• W2894889508 hasPublicationYear "2018" @default.
• W2894889508 type Work @default.
• W2894889508 sameAs 2894889508 @default.
• W2894889508 citedByCount "19" @default.
• W2894889508 countsByYear W28948895082019 @default.
• W2894889508 countsByYear W28948895082020 @default.
• W2894889508 countsByYear W28948895082021 @default.
• W2894889508 countsByYear W28948895082022 @default.
• W2894889508 crossrefType "journal-article" @default.
• W2894889508 hasAuthorship W2894889508A5003785343 @default.
• W2894889508 hasAuthorship W2894889508A5006791605 @default.
• W2894889508 hasAuthorship W2894889508A5015175349 @default.
• W2894889508 hasAuthorship W2894889508A5017211412 @default.
• W2894889508 hasAuthorship W2894889508A5024496236 @default.
• W2894889508 hasAuthorship W2894889508A5066253506 @default.
• W2894889508 hasAuthorship W2894889508A5071119117 @default.
• W2894889508 hasAuthorship W2894889508A5074213191 @default.
• W2894889508 hasAuthorship W2894889508A5074838021 @default.
• W2894889508 hasAuthorship W2894889508A5076063143 @default.
• W2894889508 hasBestOaLocation W28948895081 @default.
• W2894889508 hasConcept C118552586 @default.
• W2894889508 hasConcept C126322002 @default.
• W2894889508 hasConcept C142462285 @default.
• W2894889508 hasConcept C164866538 @default.
• W2894889508 hasConcept C187212893 @default.
• W2894889508 hasConcept C199360897 @default.
• W2894889508 hasConcept C203014093 @default.
• W2894889508 hasConcept C27415008 @default.
• W2894889508 hasConcept C2780665704 @default.
• W2894889508 hasConcept C2908647359 @default.
• W2894889508 hasConcept C2993143319 @default.
• W2894889508 hasConcept C3013748606 @default.
• W2894889508 hasConcept C41008148 @default.
• W2894889508 hasConcept C71924100 @default.
• W2894889508 hasConcept C99454951 @default.
• W2894889508 hasConceptScore W2894889508C118552586 @default.
• W2894889508 hasConceptScore W2894889508C126322002 @default.
• W2894889508 hasConceptScore W2894889508C142462285 @default.
• W2894889508 hasConceptScore W2894889508C164866538 @default.
• W2894889508 hasConceptScore W2894889508C187212893 @default.
• W2894889508 hasConceptScore W2894889508C199360897 @default.
• W2894889508 hasConceptScore W2894889508C203014093 @default.
• W2894889508 hasConceptScore W2894889508C27415008 @default.
• W2894889508 hasConceptScore W2894889508C2780665704 @default.
• W2894889508 hasConceptScore W2894889508C2908647359 @default.
• W2894889508 hasConceptScore W2894889508C2993143319 @default.

• next